Literature DB >> 23090508

Syndecans in cartilage breakdown and synovial inflammation.

Thomas Pap1, Jessica Bertrand.   

Abstract

Syndecans are transmembrane heparan sulphate proteoglycans (HSPGs) that have gained increasing interest as regulators of a variety of tissue responses, including cartilage development and remodelling. These proteoglycans are composed of a core protein to which extracellular glycosaminoglycan (GAG) chains are attached. Through these GAG chains, syndecans can interact with a variety of extracellular matrix molecules and bind to a number of soluble mediators including morphogens, growth factors, chemokines and cytokines. The structure and post-translational modification of syndecan GAG chains seem to differ not only from cell to cell, but also during different stages of cellular differentiation, leading to a complexity of syndecan function that is unique among membrane-bound HSPGs. Unlike other membrane-bound HSPGs, syndecans contain intracellular signalling motifs that can initiate signalling mainly through protein kinase C. This Review summarizes our knowledge of the biology of syndecans and the mechanisms by which binding of molecules to syndecans exert different biological effects, particularly in the joints. On the basis of the structural and functional peculiarities of syndecans, we discuss the regulation of syndecans and their roles in the developing joint as well as during degenerative and inflammatory cartilage remodelling as understood from expression studies and functional analyses involving syndecan-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090508     DOI: 10.1038/nrrheum.2012.178

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  150 in total

1.  Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development.

Authors:  M Solursh; R S Reiter; K L Jensen; M Kato; M Bernfield
Journal:  Dev Biol       Date:  1990-07       Impact factor: 3.582

2.  Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids.

Authors:  V Kainulainen; H Wang; C Schick; M Bernfield
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

3.  Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.

Authors:  Angela M Patterson; Lucy Gardner; Jennifer Shaw; Guido David; Emilie Loreau; Luc Aguilar; Brian A Ashton; Jim Middleton
Journal:  Arthritis Rheum       Date:  2005-08

4.  Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.

Authors:  C M Alexander; F Reichsman; M T Hinkes; J Lincecum; K A Becker; S Cumberledge; M Bernfield
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

6.  Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.

Authors:  F Echtermeyer; M Streit; S Wilcox-Adelman; S Saoncella; F Denhez; M Detmar; P Goetinck
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

7.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.

Authors:  G Pilia; R M Hughes-Benzie; A MacKenzie; P Baybayan; E Y Chen; R Huber; G Neri; A Cao; A Forabosco; D Schlessinger
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

8.  Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.

Authors:  Heui-Young Ryu; Jiseon Lee; Sanghwa Yang; Haein Park; Sojoong Choi; Kyeong-Cheon Jung; Seung-Taek Lee; Je-Kyung Seong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.

Authors:  Gui Su; Stacy A Blaine; Dianhua Qiao; Andreas Friedl
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

10.  The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.

Authors:  Annouck Luyten; Eva Mortier; Claude Van Campenhout; Vincent Taelman; Gisèle Degeest; Gunther Wuytens; Kathleen Lambaerts; Guido David; Eric J Bellefroid; Pascale Zimmermann
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

View more
  26 in total

Review 1.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

Review 2.  Emerging regulators of the inflammatory process in osteoarthritis.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 3.  Osteoarthritis as a disease of the cartilage pericellular matrix.

Authors:  Farshid Guilak; Robert J Nims; Amanda Dicks; Chia-Lung Wu; Ingrid Meulenbelt
Journal:  Matrix Biol       Date:  2018-05-22       Impact factor: 11.583

Review 4.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

5.  Human IGF-I propeptide A promotes articular chondrocyte biosynthesis and employs glycosylation-dependent heparin binding.

Authors:  Shuiliang Shi; Brian J Kelly; Congrong Wang; Ken Klingler; Albert Chan; George J Eckert; Stephen B Trippel
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-11-21       Impact factor: 3.770

6.  High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

Authors:  Rebecca E Wilusz; Farshid Guilak
Journal:  J Mech Behav Biomed Mater       Date:  2013-10-03

Review 7.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

8.  Transcriptome-Wide Analyses of Human Neonatal Articular Cartilage and Human Mesenchymal Stem Cell-Derived Cartilage Provide a New Molecular Target for Evaluating Engineered Cartilage.

Authors:  Rodrigo A Somoza; Diego Correa; Ivan Labat; Hal Sternberg; Megan E Forrest; Ahmad M Khalil; Michael D West; Paul Tesar; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2017-07-28       Impact factor: 3.845

Review 9.  Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk.

Authors:  Steven R Goldring; Mary B Goldring
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

Review 10.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.